Alkermes has been granted a patent for compounds aimed at treating narcolepsy or cataplexy. The patent includes related pharmaceutical compositions and methods, focusing on a specific compound formula and its acceptable salts for therapeutic use. GlobalData’s report on Alkermes gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Alkermes, was a key innovation area identified from patents. Alkermes's grant share as of June 2024 was 55%. Grant share is based on the ratio of number of grants to total number of patents.
The granted patent US12006330B2 encompasses a novel compound, referred to as Formula I, along with its pharmaceutically acceptable salts. The patent outlines a pharmaceutical composition that includes this compound or its salts combined with a suitable carrier. Furthermore, the patent details methods for treating narcolepsy and cataplexy by administering the compound or the pharmaceutical composition to individuals diagnosed with these conditions. The claims specify various structural characteristics of the compound, indicating a range of potential derivatives and modifications that may be utilized in therapeutic applications.
In addition to the primary claims, the patent includes extensive specifications regarding the compound's structure, including variations in specific components such as rings and substituents. These variations allow for a diverse array of compounds that may be effective in treating narcolepsy and cataplexy. The claims also highlight specific configurations of the compound, such as the presence of phenyl or pyridinyl rings, and the nature of certain chemical groups. This comprehensive approach not only broadens the scope of potential therapeutic agents but also provides a foundation for further research and development in the treatment of sleep disorders.
To know more about GlobalData’s detailed insights on Alkermes, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
